Zobrazeno 1 - 10
of 26
pro vyhledávání: '"M L, Brigden"'
Publikováno v:
Canadian family physician Medecin de famille canadien. 29
Nausea and vomiting are major limitations in cancer chemotherapy. Individual susceptibility to nausea varies enormously. There is no ideal antiemetic, but some work with some chemotherapeutic agents, and some are more effective in younger patients. T
Autor:
M L, Brigden
Publikováno v:
Canadian family physician Medecin de famille canadien. 31
Publikováno v:
Canadian journal of surgery. Journal canadien de chirurgie. 44(3)
To examine physicians' knowledge and actions regarding the asplenic state and to develop a practical checklist to aid in the systematic education and management of asplenic patients.A prospective cohort survey utilizing an experienced nurse practitio
Autor:
M L, Brigden
Publikováno v:
American family physician. 63(3)
Fulminant, potentially life-threatening infection is a major long-term risk after splenectomy or in persons who are functionally hyposplenic as a result of various systemic conditions. Most of these infections are caused by encapsulated organisms suc
Autor:
M L, Brigden, M, Johnston
Publikováno v:
American journal of clinical pathology. 114(2)
A survey of all licensed medical laboratories performing activated partial thromboplastin time (aPTT) testing in Canada was undertaken; the response rate was 50.7%. Preanalytic phase of testing seemed generally satisfactory, although 46% of laborator
Autor:
M L, Brigden
Publikováno v:
American family physician. 60(5)
The erythrocyte sedimentation rate (ESR) determination is a commonly performed laboratory test with a time-honored role. However, the usefulness of this test has decreased as new methods of evaluating disease have been developed. The test remains hel
Autor:
M L, Brigden, M J, Johnston
Publikováno v:
American journal of clinical pathology. 109(5)
A written survey of all licensed medical laboratories performing coagulation testing in Canada was undertaken in 1996 as a follow-up to a study performed in 1992. The an overall response rate was 77.4% of the laboratories surveyed. During the 4-year
Autor:
D V, Devine, M L, Brigden
Publikováno v:
Postgraduate medicine. 99(6)
To avoid wasting healthcare resources through overinvestigation in otherwise healthy people, it is important to remember that antiphospholipid antibodies (ie, lupus anticoagulant and anticardiolipin antibody) often do not signify clinical disease. Ho
Autor:
M L, Brigden
Publikováno v:
Postgraduate medicine. 99(6)
Careful attention to the practical aspects of oral anticoagulant therapy can improve patient compliance and lessen the risk of bleeding complications. A variety of risk factors for bleeding associated with oral anticoagulant therapy have been defined
Autor:
M L, Brigden
Publikováno v:
Postgraduate medicine. 98(3)
With use of the International Normalized Ratio (INR), physicians can accurately assess the intensity of anticoagulation in treatment programs and trials. Bleeding is the major complication of oral anticoagulant therapy, and its incidence can be lesse